Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Inteligent oligosilsesquioxane nanoconjugates of anticancer drugs with targeting moieties.

2016/21/N/ST5/03360

Keywords:

silsesquioxanes nanoconjugates anthracyclines

Descriptors:

  • ST5_10: Functional materials/nanomaterials, nanoparticles

Panel:

ST5 - Materials: materials synthesis, structure-properties relations, advanced and functional materials with designed properties, (macro)molecular architecture, material engineering

Host institution :

Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk

woj. łódzkie

Other projects carried out by the institution 

Principal investigator (from the host institution):

Kinga Piórecka 

Number of co-investigators in the project: 2

Call: PRELUDIUM 11 - announced on 2016-03-15

Amount awarded: 99 960 PLN

Project start date (Y-m-d): 2017-03-08

Project end date (Y-m-d): 2020-09-07

Project duration:: 42 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (5)
  1. Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)32, as a Complexing Nanocarrier for Doxorubicin and Daunorubicin
    Authors:
    Kinga Piorecka, Anna Janaszewska, Marta Majkowska, Monika Marcinkowska, Jan Kurjata, Slawomir Kazmierski, Ewa Radzikowska-Cieciura, Bartlomiej Kost, Przemyslaw Sowinski, Barbara Klajnert-Maculewicz, Wlodzimierz A. Stanczyk
    Academic press:
    Materials (rok: 2020, tom: 13, strony: 5512), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ma13235512 - link to the publication
  2. Novel Polyhedral Silsesquioxanes [POSS(OH)32] as Anthracycline Nanocarriers—Potential Anticancer Prodrugs
    Authors:
    Kinga Piorecka, Jan Kurjata, Wlodzimierz A. Stanczyk
    Academic press:
    Molecules (rok: 2021, tom: 26, strony: 47), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/molecules26010047 - link to the publication
  3. Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane
    Authors:
    Kinga Piorecka, Jan Kurjata, Irena Bak-Sypien, Marek Cypryk, Urszula Steinke, Wlodzimierz A. Stanczyk
    Academic press:
    RSC Advances (rok: 2020, tom: 10, strony: 15579-15585), Wydawca: ROYAL SOCIETY OF CHEMISTRY
    Status:
    Published
    DOI:
    10.1039/d0ra01319f - link to the publication
  4. Synthetic routes to nanoconjugates of anthracyclines
    Authors:
    Kinga Piorecka, David Smith, Jan Kurjata, Maciej Stanczyk, Włodzimierz A. Stanczyk
    Academic press:
    Bioorganic Chemistry (rok: 2020, tom: 96, strony: 103617), Wydawca: elsevier
    Status:
    Published
    DOI:
    10.1016/j.bioorg.2020.103617 - link to the publication
  5. Synthetic routes to nanomaterials containing anthracyclines: noncovalent systems
    Authors:
    Kinga Piorecka, Jan Kurjata, Maciej Stanczyk and Włodzimierz A. Stanczyk
    Academic press:
    Biomaterials Science (rok: 2018, tom: 6, strony: 2552-2565), Wydawca: ROYAL SOCIETY OF CHEMISTRY
    Status:
    Published
    DOI:
    10.1039/C8BM00739J - link to the publication